Skip directly to page options Skip directly to A-Z link
Volume 6, Number 4—August 2000
Research

Reemergence of Pertussis in the Highly Vaccinated Population of The Netherlands: Observations on Surveillance Data

Hester E. de MelkerComments to Author , J.F.P. Schellekens, S.E. Neppelenbroek, F.R. Mooi, H.C. Rümke, and M.A.E. Conyn-van Spaendonck
Author affiliations: National Institute of Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table 2

Reported cases according to vaccination status and estimate of vaccine-effectiveness according to method of diagnosis

1- to 4- yr-olds Vaccine efficacy 5- to 9- yr-olds Vaccine efficacy
Year Method of diagnosis (N) (%)a (N) (%)a
1993 Microbiologic 14 93 14 94
2-point serology 25 91 28 75
1-point serology 24 79 26 50
Otherb 35 96 20 90
Total 98 93 88 84
1994 Microbiologic 23 56 15 42
2-point serology 36 67 36 83
1-point serology 63 71 65 c
Otherb 37 89 29 91
Total 159 77 145 72
1995 Microbiologic 14 85 9 67
2-point serology 27 82 19 64
1-point serology 39 64 45 c
Otherb 37 53 27 67
Total 117 72 100 45
1996 Microbiologic 116 67 123 3
2-point serology 245 c 288 49
1-point serology 545 c 782 c
Otherb 290 66 355 40
Total 1196 34 1548 16
1997 Microbiologic 63 51 68 57
2-point serology 110 c 131 c
1-point serology 283 c 345 c
Otherb 244 c 260 c
Total 700 c 804 c

aEstimated vaccine effectiveness; a vaccine-coverage of 96% was used to estimate the incidence and vaccine effectiveness.
bEpidemiologic, serologic (differentiation between positive two-point serology and positive one-point serology not possible), clinical or method of diagnosis unknown.
c Vaccine effectiveness could not be estimated as the percentage vaccinated was more than 96%.

Main Article

1Vaccine effectiveness = 1 – (proportion of vaccinated cases/1 – proportion of vaccinated cases) X (1 – proportion vaccinated in the population/proportion vaccinated in the population).

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external